+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Biologic Therapeutic Drugs: Technologies and Global Markets - Product Thumbnail Image

Biologic Therapeutic Drugs: Technologies and Global Markets

  • Report
  • May 2025
  • 170 Pages
  • Global
From
Brugada Syndrome - Global Strategic Business Report - Product Thumbnail Image

Brugada Syndrome - Global Strategic Business Report

  • Report
  • July 2025
  • 463 Pages
  • Global
From
Turkey Generic Drugs Market Competition Forecast and Opportunities, 2028 - Product Thumbnail Image

Turkey Generic Drugs Market Competition Forecast and Opportunities, 2028

  • Report
  • August 2023
  • 76 Pages
  • Turkey
From
Light Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal Therapies - Distribution by Target Indications, Key Players and Geographies: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Light Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal Therapies - Distribution by Target Indications, Key Players and Geographies: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • September 2021
  • 140 Pages
  • Global
From
Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 269 Pages
  • Global
From
B-cell Lymphoma- Pipeline Insight, 2025 - Product Thumbnail Image

B-cell Lymphoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Waldenstrom Macroglobulinemia - Pipeline Insight, 2025 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Precision Oncology - Global Strategic Business Report - Product Thumbnail Image

Precision Oncology - Global Strategic Business Report

  • Report
  • July 2025
  • 382 Pages
  • Global
From
Invasive Ductal Carcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Invasive Ductal Carcinoma Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 375 Pages
  • Global
From
NUT Midline Carcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

NUT Midline Carcinoma Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 383 Pages
  • Global
From
Breast Adenocarcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Breast Adenocarcinoma Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 294 Pages
  • Global
From
Lung Adenocarcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Lung Adenocarcinoma Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 291 Pages
  • Global
From
Metastatic Lung Adenocarcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Metastatic Lung Adenocarcinoma Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 286 Pages
  • Global
From
Blockbuster Oncology Brands - Global Strategic Business Report - Product Thumbnail Image

Blockbuster Oncology Brands - Global Strategic Business Report

  • Report
  • July 2025
  • 284 Pages
  • Global
From
Systemic Lupus Erythematosus - Pipeline Review, H2 2020 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 816 Pages
  • Global
From
Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 204 Pages
  • Global
From
Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 94 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
Loading Indicator